Efficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis Syndrome

about

Efficacy of Single Dose Rasburicase (1.5 mg) for Prophylaxis and Management of Laboratory Tumor Lysis Syndrome

Item

http://www.wikidata.org/entity/Q58125072

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Efficacy of Single Dose Rasbur ...... aboratory Tumor Lysis Syndrome

@en

Efficacy of Single Dose Rasburicase

@nl

type

Item

label

Efficacy of Single Dose Rasbur ...... aboratory Tumor Lysis Syndrome

@en

Efficacy of Single Dose Rasburicase

@nl

prefLabel

Efficacy of Single Dose Rasbur ...... aboratory Tumor Lysis Syndrome

@en

Efficacy of Single Dose Rasburicase

@nl

P1476

Efficacy of Single Dose Rasbur ...... aboratory Tumor Lysis Syndrome

@en

P2093

Ashwin Philips

http://www.w3.org/2001/XMLSchema#string

Jaikumar Ramamurthy

http://www.w3.org/2001/XMLSchema#string

Manikandan Dhanushkodi

http://www.w3.org/2001/XMLSchema#string

Prasanth Ganesan

http://www.w3.org/2001/XMLSchema#string

T G Sagar

http://www.w3.org/2001/XMLSchema#string

T S Ganesan

http://www.w3.org/2001/XMLSchema#string

P2860

The tumor lysis syndrome

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.

Tumour lysis syndrome: new therapeutic strategies and classification.

Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome.

Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study

Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients.

Management of tumor lysis syndrome with a single fixed dose of rasburicase in Asian lymphoma patients: a case series and literature review.

Comparative evaluation of single fixed dosing and weight-based dosing of rasburicase for tumor lysis syndrome.

Fixed, low-dose rasburicase for the treatment or prevention of hyperuricemia in adult oncology patients.

Single 4.5 mg fixed-dose of rasburicase for hyperuricemia associated with tumor lysis syndrome.

P2888

s12288-018-0938-9

P304

618-622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12288-018-0938-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Venkatraman Radhakrishnan

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30369730

http://www.w3.org/2001/XMLSchema#string

P921

hematology

P932

6186245

http://www.w3.org/2001/XMLSchema#string